Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
4,281
4,373
4,655
4,451
4,138
4,088
Hasılat Artışı (YoY)
-3%
-6%
5%
8%
1%
6%
Satınalma Maliyeti
2,763
2,830
2,975
2,996
2,722
2,593
Brüt Kâr
1,518
1,542
1,680
1,455
1,416
1,494
Satış, Genel ve İdari
1,034
1,112
1,274
1,163
1,070
1,104
Araştırma ve Geliştirme
101
112
122
123
122
121
İşletme Giderleri
1,125
1,230
1,396
1,289
775
1,222
Diğer Finansman Gelirleri (Giderleri)
-10
2
12
-51
-23
-111
Kâr Öncesi Gelir
103
-80
-8
-139
258
5
Kira Vergisi Gideri
133
80
-3
-8
389
-38
Net Kâr
-51
-171
-12
-140
-68
-162
Net Income Growth
Kâr Artışı
-68%
1,325%
-91%
106%
-57.99%
-211%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
138.9
137.4
135.3
134.5
133.6
136.1
Hisse Değişimi (Yıllık Üst Üste)
1%
2%
1%
1%
-2%
0%
EPS (Diluted)
-0.37
-1.25
-0.09
-1.04
-0.51
-1.19
EPS Artışı
-68%
1,289%
-91%
104%
-56.99%
-211%
Öz sermaye akışı
271
244
303
210
-66
430
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
35.45%
35.26%
36.09%
32.68%
34.21%
36.54%
Faaliyet Kâr Marjı
9.18%
7.11%
6.1%
3.72%
15.49%
6.65%
Kâr Marjı
-1.19%
-3.91%
-0.25%
-3.14%
-1.64%
-3.96%
Özsermaye Karlılık Oranı
6.33%
5.57%
6.5%
4.71%
-1.59%
10.51%
EBITDA
724
636
643
504
953
656
EBITDA Marjinali
16.91%
14.54%
13.81%
11.32%
23.03%
16.04%
D&A EBITDA için
331
325
359
338
312
384
Faaliyet Kârı
393
311
284
166
641
272
Faaliyet Kâr Marjı
9.18%
7.11%
6.1%
3.72%
15.49%
6.65%
Verilen Vergi Oranı
129.12%
-100%
37.5%
5.75%
150.77%
-760%
Önemli İstatistikler
Önceki Kapanış
$14.38
Açılış fiyatı
$14.54
Günün Aralığı
$14.32 - $14.69
52 haftalık aralık
$12.17 - $30.93
İşlem hacmi
498.7K
Ort.Hacim
3.4M
EPS (TTM)
-0.38
Dividend yield
7.76%
Piyasa Değeri
$1.9B
PRGO nedir?
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin and currently employs 8,379 full-time employees. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.